QIAGEN (QGEN)
(Delayed Data from NYSE)
$42.99 USD
+0.24 (0.56%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $42.99 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth A Momentum D VGM
Balance Sheet
Fiscal Year End for QIAGEN NV falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,058 | 1,418 | 1,065 | 729 | 867 |
Receivables | 382 | 324 | 362 | 440 | 427 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 398 | 358 | 328 | 291 | 171 |
Other Current Assets | 310 | 294 | 355 | 207 | 105 |
Total Current Assets | 2,148 | 2,394 | 2,110 | 1,667 | 1,570 |
Net Property & Equipment | 765 | 662 | 638 | 559 | 455 |
Investments & Advances | 3 | 131 | 190 | 379 | 192 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 73 | 55 | 57 |
Intangibles | 3,003 | 2,897 | 2,978 | 3,090 | 2,773 |
Deposits & Other Assets | 197 | 203 | 158 | 162 | 188 |
Total Assets | 6,115 | 6,288 | 6,147 | 5,913 | 5,236 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 84 | 99 | 101 | 118 | 85 |
Current Portion Long-Term Debt | 588 | 390 | 848 | 43 | 285 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 407 | 486 | 569 | 346 | 444 |
Income Taxes Payable | 0 | 0 | 0 | 57 | 34 |
Other Current Liabilities | 0 | 0 | 0 | 51 | 103 |
Total Current Liabilities | 1,079 | 975 | 1,517 | 615 | 951 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 38 | 39 | 23 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 922 | 1,472 | 1,094 | 1,880 | 1,421 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 306 | 375 | 401 | 580 | 303 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 2,307 | 2,821 | 3,050 | 3,115 | 2,699 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 3 | 3 | 3 | 3 | 3 |
Capital Surplus | 1,915 | 1,868 | 1,819 | 1,834 | 1,777 |
Retained Earnings | 2,457 | 2,160 | 1,792 | 1,323 | 1,178 |
Other Equity | -434 | -404 | -327 | -244 | -310 |
Treasury Stock | 133 | 160 | 190 | 118 | 112 |
Total Shareholder's Equity | 3,808 | 3,467 | 3,097 | 2,798 | 2,537 |
Total Liabilities & Shareholder's Equity | 6,115 | 6,288 | 6,147 | 5,913 | 5,236 |
Total Common Equity | 3,808 | 3,467 | 3,097 | 2,798 | 2,537 |
Shares Outstanding | 228.20 | 220.80 | 221.10 | 221.10 | 220.90 |
Book Value Per Share | 16.69 | 15.70 | 14.01 | 12.65 | 11.48 |
Fiscal Year End for QIAGEN NV falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,058 | 1,016 | 1,332 | 1,287 | 1,418 |
Receivables | 382 | 327 | 313 | 317 | 324 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 398 | 399 | 392 | 381 | 358 |
Other Current Assets | 310 | 221 | 275 | 266 | 294 |
Total Current Assets | 2,148 | 1,962 | 2,311 | 2,251 | 2,394 |
Net Property & Equipment | 765 | 706 | 707 | 691 | 662 |
Investments & Advances | 3 | 63 | 98 | 92 | 131 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 3,003 | 2,977 | 3,027 | 3,039 | 2,897 |
Deposits & Other Assets | 197 | 198 | 205 | 206 | 203 |
Total Assets | 6,115 | 5,907 | 6,347 | 6,279 | 6,288 |
Liabilities & Shareholders Equity | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 84 | 77 | 84 | 84 | 99 |
Current Portion Long-Term Debt | 588 | 101 | 500 | 393 | 390 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 407 | 347 | 394 | 413 | 486 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 1,079 | 524 | 978 | 890 | 975 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 922 | 1,382 | 1,388 | 1,487 | 1,472 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 306 | 357 | 341 | 375 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 2,307 | 2,213 | 2,724 | 2,718 | 2,821 |
Shareholders Equity | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 3 | 3 | 3 | 3 | 3 |
Capital Surplus | 1,915 | 1,903 | 1,890 | 1,882 | 1,868 |
Retained Earnings | 2,457 | 2,361 | 2,283 | 2,215 | 2,160 |
Other Equity | -434 | -439 | -418 | -396 | -404 |
Treasury Stock | 133 | 134 | 134 | 143 | 160 |
Total Shareholder's Equity | 3,808 | 3,694 | 3,624 | 3,561 | 3,467 |
Total Liabilities & Shareholder's Equity | 6,115 | 5,907 | 6,347 | 6,279 | 6,288 |
Total Common Equity | 3,808 | 3,694 | 3,624 | 3,561 | 3,467 |
Shares Outstanding | 228.20 | 221.10 | 220.80 | 220.80 | 220.80 |
Book Value Per Share | 16.69 | 16.71 | 16.41 | 16.13 | 15.70 |